The structure of ibogaine
G. Arai, J. C. Coppola, G. A. Jeffrey
Acta Crystallographica July 10, 1960 Peer reviewed DOI: 10.1107/s0365110x60001369 via OpenAlex
Abstract
No abstract available from the source.
Related reading
- Exploring the Therapeutic Potential of Psilocybin and Ketamine in Major Depressive Disorder including Treatment-Resistant Depression: A Narrative Review Biuletyn Głównej Biblioteki Lekarskiej • June 1, 2025 • via OpenAlex
- A dual-receptor model of serotonergic psychedelics April 15, 2024 • via OpenAlex
- The Efficacy and Safety of Ibogaine Treatment for Substance Use Disorders - A Narrative Review Quality in Sport • April 2, 2026 • via OpenAlex
- Neurorestorative Properties of Ibogaine: Linking Multi-Receptor Affinities to Remyelination and Metabolic Restoration Acta Neuropsychiatrica • February 13, 2026 • via OpenAlex
- Ibogaine: Therapeutic Potential, Cardiac Safety, and Translational Perspectives in the Treatment of Substance Use Disorders—A Scoping Review Molecules • February 4, 2026 • via OpenAlex